Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study - Concepedia

Concepedia

Publication | Open Access

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

DOI Full Paper Access

361

Citations

30

References

2017

Year

Désirée van der Heijde, Atul Deodhar, James Cheng‐Chung Wei, Edit Drescher, Dona Fleishaker, Thijs Hendrikx, David Li, Sujatha Menon, Keith S. Kanik

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1